Evofem Biosciences, Inc. (EVFM) Income Annual - Discounting Cash Flows
EVFM
Evofem Biosciences, Inc.
EVFM (OTC)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing 2026-03-11 2026-03-11 2025-03-24 2023-12-31 2023-04-27 2022-03-10 2021-03-04 2020-03-12 2019-03-01 2018-02-26 2017-03-23 2016-03-29 2015-03-26 2013-12-31 2012-12-31
Revenue 20.18 20.18 19.36 18.22 16.84 8.24 0.446 0 0 0 0 0 0 0 0.1
Cost of Revenue 5.12 5.12 3.83 6.51 4.42 4.05 1.65 0.905 0.262 0.244 0.069 0.058 0.018 0.072 0.1
Gross Profit 15.07 15.07 15.53 11.71 12.42 4.19 -1.2 -0.905 -0.262 -0.244 -0.069 -0.058 -0.018 -0.072 0
Operating Expenses 13.63 13.63 23.2 29.55 96.55 171 102.4 51.84 77.38 35.44 11.97 41.99 9.57 14.35 5.74
Research & Development 3.45 3.45 1.84 2.94 25.03 33.13 17.05 22.23 43.41 23.54 6.58 34.41 5.17 11.45 3.25
Selling, General and Administrative 17.07 17.07 20.74 26.61 71.51 137.9 85.37 29.61 33.97 11.9 5.39 7.58 4.4 2.9 2.47
Other Operating Expenses -6.89 -6.89 0.619 0 0 0 0 0 0 0 0 0 0 0 0.024
Operating Income 1.44 1.44 -7.68 -17.85 -84.12 -166.8 -103.6 -52.74 -77.64 -35.69 -12.04 -42.05 -9.59 -14.42 -5.74
Net Non-Operating Interest -0.676 -2.62 0.016 0.031 0.085 0.015 0.169 0.458 0.127 0.128 -0.976 -1.11 -0.367 -0.055 -0.935
Interest Income 0.015 0.015 0.016 0.031 0.085 0.015 0.169 0.458 0.127 0.128 0.059 0.026 0.008 0.001 0.002
Interest Expense 0.691 2.63 0 0 0 0 0 0 0 0 1.04 1.13 0.375 0.057 0.937
Equity & Other Income/(Expense) -0.37 1.57 -1.2 70.81 7.38 -38.39 -38.85 -27.75 -48.2 -69.74 0 0 -0.861 -0.538 -1.15
Income Before Tax 0.393 0.393 -8.86 53 -76.65 -205.2 -142.3 -80.03 -125.7 -105.3 -13.02 -43.16 -10.82 -15.02 -7.83
Income Tax Expense 0.01 0.002 0 0.017 0.044 0.017 0.004 0.004 0.002 0.003 0 0 0 0 0
Income Attributable to Non-Controlling Interest -0.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income 0.391 0.391 -8.86 52.98 -76.7 -205.2 -142.3 -80.03 -125.7 -105.3 -13.02 -43.16 -10.82 -15.02 -7.83
Depreciation and Amortization 0.626 0.626 0.756 1.78 2.05 1.02 1.18 0.905 0.262 0.244 0.069 0.058 0.018 0.072 0.124
EBITDA 2.06 2.06 -6.92 -16.07 -82.08 -165.8 -102.4 -51.84 -77.38 -35.44 -11.97 -41.99 -9.57 -14.35 -5.62
Earnings Per Share (EPS) 0.001 0.002 -0.092 10.36 -164.6 -2,962 -3,973 -3,730 -10,763 -85,614 -10,612 -35,449 -8,690 -11,799 -6,150
Diluted Earnings Per Share -0.007 0 -0.092 0.051 -164.6 -2,962 -3,973 -3,730 -10,763 -85,614 -10,612 -35,449 -8,690 -11,799 -6,150
Weighted Average Shares Outstanding 123.7 123.7 96.46 4.83 0.466 0.07 0.036 0.021 0.012 0.001 0.001 0.001 0.001 0.001 0.001
Diluted Weighted Average Shares Outstanding 6,422 6,422 96.46 984 0.466 0.07 0.036 0.021 0.012 0.001 0.001 0.001 0.001 0.001 0.001
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program